Nordic Webinar on Complement targeted therapy
Wednesday 18 March
15:30 – 17:00
About the event
Organizer: Bonnier Healthcare Nordic c/o Dagens Medisin AS
Nordic Webinar on Complement targeted therapy
C3-Targeted Therapy in C3G and Primary IC-MPGN
The program is subject to ongoing updates.
Moderator: Professor Stefan Jacobson, Department of Nephrology, Karolinska Institutet Danderyd Hospital, Stockholm, Sweden
A deeper dive into the VALIANT phase 3 study data
Professor in Nephrology, Fadi Fakhouri, Head of Nephrology and Hypertension, Lausanne University Hospital “CHUV”, Switzerland (digital)
Where Does Complement Inhibition Fit Within the Treatment Paradigm for ANCA-Associated Vasculitis and igAN?
Professor in Nephrology, Annette Bruchfeld, FERA, Senior Physician Linköping and Karolinska University Hospital
Nordic Webinar on Complement targeted therapy
Wednesday 18 March
15:30 – 17:00
About the event
Organizer: Bonnier Healthcare Nordic c/o Dagens Medisin AS
Nordic Webinar on Complement targeted therapy
C3-Targeted Therapy in C3G and Primary IC-MPGN
The program is subject to ongoing updates.
Moderator: Professor Stefan Jacobson, Department of Nephrology, Karolinska Institutet Danderyd Hospital, Stockholm, Sweden
A deeper dive into the VALIANT phase 3 study data
Professor in Nephrology, Fadi Fakhouri, Head of Nephrology and Hypertension, Lausanne University Hospital “CHUV”, Switzerland (digital)
Where Does Complement Inhibition Fit Within the Treatment Paradigm for ANCA-Associated Vasculitis and igAN?
Professor in Nephrology, Annette Bruchfeld, FERA, Senior Physician Linköping and Karolinska University Hospital